It is hard to keep up now with the amount of material from a variety of sources documenting the failure of the Covid vaccines. By way of a running conclusion, Dr Peter McCullough has said that the available evidence, such as the failure of the vaccines to deal with the Omicron variant shows that the vaccines do not work, and that the vaccine mandates should be abandoned. Dr McCullough gives a good non-technical summary of the literature indicating that the vaccines have failed. For anti-vaxxers who want more detail some abstracts of the most important recent papers is also given.
“The COVID-19 vaccines have largely failed in stopping the transmission of the CCP (Chinese Communist Party) virus, especially for the most recent Omicron variant, so the vaccine mandate should be thrown away, according to Dr. Peter McCullough.
“The vaccines themselves have basically now become obsolete as the virus has continued to mutate,” McCullough told NTD’s “Capitol Report” in an interview broadcast on Wednesday. “So at this point of time, the vaccine mandates have to be dropped across the board.”
McCullough said some recent studies have shown the effectiveness of the COVID-19 vaccines dropped significantly with the new variants.
“There’s a paper by Young-Xu in JAMA, the prior Delta strain that was only about 20 percent covered by the vaccines. Vaccines were very ineffective against Delta,” McCullough said.
The study, which is peer-reviewed and published on the Journal of the American Medical Association (JAMA) last month, found that during the high-Delta period, the estimated vaccine effectiveness was 62.0 percent in the first month and decreased to 57.8 percent by month three. The decrease in vaccine effectiveness accelerated after month four, reaching a low of approximately 20 percent in months five through seven.
“And now a paper from Hansen from Denmark, and from the UK public health security report indicated, against Omicron the vaccines are basically ineffective,” McCullough continued.
The Danish study, a preprint and has not been peer-reviewed, found that vaccine effectiveness against Omicron was initially 55.2 percent and 36.7 percent for Pfizer and Moderna vaccines, respectively, but waned rapidly over time. By comparison, vaccine effectiveness against Delta was significantly higher and better preserved over the same period.
The vaccine effectiveness is re-established to 54.6 percent upon revaccination—a booster—of a Pfizer vaccine, the study claimed.
The UK Health Security Agency report released on Dec. 31 also found that vaccine effectiveness against the Omicron variant is significantly lower than compared to the Delta variant and wanes rapidly.
“Among those who had received 2 doses of AstraZeneca, there was no effect against Omicron from 20 weeks after the second dose. Among those who had received 2 doses of Pfizer or Moderna, effectiveness dropped from around 65 to 70 percent down to around 10 percent by 20 weeks after the second dose,” the report (pdf) states.
The Centers for Disease Control and Prevention (CDC) has been saying the COVID-19 vaccines are “safe and effective,” and serious adverse events are rare.
“The only thing the vaccines could have done is reduce the chances of getting COVID-19. … So many millions of Americans who have taken the vaccines have been disappointed to find out they contracted COVID-19 anyway,” McCullough continued.
On Wednesday, the CDC published a study showing protection from prior infection, or so-called natural immunity, was better than the protection from COVID-19 vaccines against the Delta variant.
McCullough also said the vaccine mandates lack the ethical or legal standing in the first place because the COVID-19 vaccines are “investigational.”
“All the vaccines are still investigational and in research. Mandates had no ethical or moral or legal standing from that perspective. No one can be forced into research against their will or be coerced into it.”
A spokesperson from the Food and Drug Administration (FDA), didn’t answer directly whether COVID-19 vaccines are investigational, but told The Epoch Times that “all of the vaccines are under an EUA except for Comirnaty, which is fully approved.”
In a guidance (pdf) issued last year, FDA said emergency use authorizations (EUAs) are issued for investigational vaccines to prevent COVID-19 during the pandemic.
“We can’t have Americans have fear about losing their job or school or travel related to a failed vaccine,” McCullough said. “But even more so we need to re-examine what we’ve done with respect to our public health priorities and COVID-19.”
McCullough said that in March and April 2020 America should have had large randomized trials and moved very quickly into studying multi-drug treatment. However, the federal authorities refused to do so and made a big push for vaccines.
McCullough also shared the treatment for COVID-19 patients with the Omicron variant.
“Fortunately with the Omicron variants very mild, the main treatment is oral nasal virucidal washes with dilute povidone-iodine or hydrogen peroxide 12. Clinical trials show the biggest benefit of that is more than any other form of treatment,” McCullough said.
Occasionally patients may need additional oral drugs and Pfizer and Merck pills could be featured, the renowned cardiologist and epidemiologist added.
“And for severe cases we can use Sotrovimab, which is the GSK monoclonal antibody, may be in a high-risk senior or special case,” McCullough said.
“The vaccines aren’t treatment, they offered no hope of treating a patient once they contracted COVID-19. And we knew with respiratory virus they were very unlikely to be effective,” said the doctor.
The CDC has been saying that the COVID-19 vaccines could reduce severe illness and death, and vaccinated people should get a booster to keep up the protection.”
https://www.medrxiv.org/content/10.1101/2021.12.20.21267966v3
“Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth
doi: https://doi.org/10.1101/2021.12.20.21267966
ABSTRACT
In this brief communication we are showing original research results with early estimates from Danish nationwide databases of vaccine effectiveness (VE) against the novel SARS-CoV-2 Omicron variant (B.1.1.529) up to five months after a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines.
Our study provides evidence of protection against infection with the Omicron variant after completion of a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines; in particular, we found a VE against the Omicron variant of 55.2% (95% confidence interval (CI): 23.5 to 73.7%) and 36.7% (95% CI: -69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, in the first month after primary vaccination. However, the VE is significantly lower than that against Delta infection and declines rapidly over just a few months. The VE is re-established upon revaccination with the BNT162b2 vaccine (54.6%, 95% CI: 30.4 to 70.4%).”
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787183
December 15, 2021
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
Yinong Young-Xu, ScD1,2; Gabrielle M. Zwain, BA1; Ethan I. Powell, BA1; et alJeremy Smith, MPH1
JAMA Netw Open. 2021;4(12):e2138975. doi:10.1001/jamanetworkopen.2021.38975
Introduction
In a recent study that estimated COVID-19 messenger RNA (mRNA) vaccine effectiveness, we found that the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines were highly effective against SARS-CoV-2 infection before June 2021 among 1 363 180 US veterans who were vaccinated in January and February of 2021. Transmission of the SARS-CoV-2 Delta variant increased rapidly during the summer of 2021, and waning COVID-19 mRNA vaccine effectiveness has been reported. Therefore, we reexamined the estimated effectiveness of the 2 COVID-19 mRNA vaccines (mRNA-1273 and BNT162b2) during July to September 2021 among fully vaccinated male veterans aged 65 years or older.
https://www.theepochtimes.com/its-time-to-put-the-pandemic-era-behind-us_4229629.html